Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer ; volume:9 ; number:1 ; day:23 ; month:1 ; year:2007 ; pages:1-9 ; date:2.2007
Breast cancer research ; 9, Heft 1 (23.1.2007), 1-9, 2.2007
- Creator
-
Wegman, Pia
- Contributor
-
Elingarami, Sauli
Carstensen, John
Stål, Olle
Nordenskjöld, Bo
Wingren, Sten
SpringerLink (Online service)
- DOI
-
10.1186/bcr1640
- URN
-
urn:nbn:de:1111-2016032362649
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wegman, Pia
- Elingarami, Sauli
- Carstensen, John
- Stål, Olle
- Nordenskjöld, Bo
- Wingren, Sten
- SpringerLink (Online service)
Other Objects (12)
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
Erratum To: Genetic variants in the MRPS30region and postmenopausal breast cancer risk
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
Genetic polymorphisms analysis of CYP2D6 in the Uygur population
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
Erratum To: Genetic variants in the MRPS30region and postmenopausal breast cancer risk
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
Genetic polymorphisms analysis of CYP2D6 in the Uygur population
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Overcoming CYP2D6-mediated tamoxifen resistance in postmenopausal breast cancer : a PBPK approach
Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer
Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen
Influence of CYP2D6 genotype on tamoxifen efficacy in advanced breast cancer
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study
Erratum To: Genetic variants in the MRPS30region and postmenopausal breast cancer risk
Frequencies of CYP2D6 genetic polymorphisms in Arab populations
Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
Genetic polymorphisms analysis of CYP2D6 in the Uygur population